is…out the door and not looking back…
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Trash TC if anyone wants, I get it, but the best thing to happen to LQMT is still to have seen Paul HA(u)CK, Executive VP of (NO)Sales disappear, who apparently took Sean Angus (Beef) with hiLOL.
Bye fellas, hope you didn't let the door hit you in the ass! And thanks for dumping out Paulie when you saw you were a COMPLETE FAILURE as a "sales" person!
Lol, ok, I'm done...damn I HATE that guy! I feel sorry for his dogs, though, Lol.
LOVIN’ THE OPTIMISM!!!
And I just saw Jackson Browne, so that’s very timely. Thank you. He was GREAT, by the way.
No offense taken at all. You were just providing additional info. Thanks.
And, yeah I'm fine with being reminded if I'm wrong. I got it right the first time on the flip, although I would have liked to flip at 35+, instead of 26+ (lol, damn, I'm almost like Higgins), but they kept freezing trading. Have a good one.
Lol, check out his photo. Probably senility, with greed and stupidity mixed in. He left 300k on the table. Agree, though.
http://investor.neurometrix.com/management/thomas-higgins
I still think there's going to be a good next Q, despite this dope's sale. Don't hesitate to remind me if I'm wrong, though.
I do this kind of work. He actually exercised options at 1.57, then flipped them out.
He's still a jerk, and a dope, for flipping out now. They need a new CFO.
Thanks for the info.
I didn't see that he got them at that price. Either way, the dope lost 300k, minimum, by not holding until Friday. (17-18.50 less the 10.55 he sold at times 50k shs).
I'm mixed as to whether or not it's truly a sign, but I get your point. If he had sold at the top, I'd give him some cred, but he didn't and I think those shares, if at the price which you noted, which I'm not disputing you, were his "gift" for getting the 14 mill in.
Way to sell, Higgins, you dope, you didn't come anywhere near the top - 10.55 - duh.
https://ih.advfn.com/stock-market/NASDAQ/neurometrix-NURO/stock-news/85932917/statement-of-changes-in-beneficial-ownership-4
Anyone know what options this jackass still has a right to? He's got 24K shares left, that I see in that Form 4.
I don’t think I’m going out on a limb to say that when you own a stock like this and you listen to a site (won’t give them credit even by mentioning their name) that posts YouTube videos with a hip hop beat in the background, you can pretty much dismiss it. They got NURO 100% wrong, but take a guess if they weren’t selling pre-market.
I’ll hold until earnings. My basis is low enough that if I get hit, I’ll suck it up, but I think they’re primed for a strong Q with this being the first full Q after FDA approval and being able to market that approval to ALL pain management caregivers.
He should rap the chart analysis…
Buy at 11 or below, flip, or hold into earnings. They’re an MIT spinoff, brilliant CEO, FDA approval (which is almost impossible for such a small company), huge market for device, huge g.p. margins (think it’s at least 75%), and they just had the 424b filing for 14 mill, which is probably about 90% for inventory buildup.
They’re floating 14 mill for inventory. They are not tied to manufacturing in China. Their GP % is unreal.
Agreed, it may drop, but I think they’re going to have a really, really strong Q. Last one was very good, but that had just literally received FDA approval. Now they have a full Q of FDA approval, but don’t hesitate to remind me when I’m wrong…
They manufacture in Woburn. For the initial orders, I don’t see supply chain issues.
I think I'm going to ride out the manipulation until earnings. The bigger players are screwing with the low float.
They're not doing the 14 mill issuance for admin costs.
Do you know where they're manufacturing this? Is it in Mass or in China? I know, I'm being lazy. If you don't know, I'll check it out in the 10K or Q and let you know, if you're interested.
https://www.marketsandmarkets.com/Market-Reports/neurostimulation-devices-market-921.html
Below 100 mill market cap, FDA approval, selling into a 5 BILLION market.
You’re right, we could speculate until the cows come home and then they do a 180/of what seems to make sense and they end up right and me wrong. What else is new? Lol.
What’s your take? This is interesting, but it’s always tough to figure out what’s going on here. Goog giving up on it?
Cook, and Apple’s counsel, already have this figured out. You know he’s got a “Plan B.” He may not be an “innovator,” but he is a master of distribution and profitability. Cook has another avenue to fill in any gap, or he’s going to charge them more to be an Apple “end.” There’s always a trapdoor when a competitor, or adversary, thinks they beat Apple and then Apple usually comes back stronger, which helps out a shareholder’s portfolio value, too.
Already close to 4 mill shs traded pre-market and futures looking positive - macro/micro externals look good.
No, I totally mucked up. I was looking at it yesterday and stupidly, had my chance, but didn’t pull the trigger. In a way, doesn’t matter, as I’m figuring earnings will push this into the 20’s, or more.
I’m thinking that with all the pre-market activity. Volume is building. I just bought in pre-market at 13.49. Good luck to us today…
Buying pre-market. If it hits 20 today, I’m flipping it. If not, I’m holding it to earnings and will ride it out. The market cap is too small right now for a Company with FDA approval on a product that has the potential to help 10’s of millions of people.
Dammit, I missed it! Yes, I think you’re right.
I wish I had grabbed that under 10. I’ll probably jump in tomorrow for 1,000 shares. It’s going to have a ton of volatility, but I think the earnings will be very strong for the next Q and if it doesn’t pay off now, it will by then.
You are VERY WELCOME, sir!
Why, thank you, I appreciate the comment.
Yes, you, of course, you. Great info, with a lot of terrific clarity. And, as an FYI, you provide REAL research, not ad hoc, gobbledygook with zero basis in fact and worthless speculation.
So, you provide a lot of great information with a lot of clarity.
Not yet, trying to time the bottom, which means I’ll likely miss it…
I didn’t read it in detail, but I’m guessing the 14 mill raised was to (mostly) ramp up inventory. I hadn’t looked at their financials until now, as I was flipping it on that run-up, but their current ratio is outstanding; it’s 7-1 and their quick asset ratio is 5-1. Their gross profit margin is huge - 75%.
I don’t know if you’ve read about the CEO, but his background is incredible. They’ve got the foundation, now they have to build on it, although I wish I was in at $1, but that’s like a lottery…
I’m not going to wait long, though - I “gotta fish or cut bait.”
Shai Gozani is an impressive guy -
Shai N. Gozani, M.D., Ph.D.
Chairman of the Board, President, and Chief Executive Officer
Dr. Gozani founded NeuroMetrix, Inc. in 1996 as a spin-off from the Massachusetts Institute of Technology. He currently serves as Chairman of the board of directors and as our President and Chief Executive Officer. Dr. Gozani has led the Company from a venture capital backed start-up, through an initial public offering on Nasdaq, through development of a successful diagnostics business, and presently into the wearable technology sector. Over 2.5 million patients have benefited from the Company’s technology over the past 15 years.
Dr. Gozani has published over 30 peer-reviewed scientific articles and has been awarded 25 US and international patents. Dr. Gozani holds a B.A. degree in Computer Science, a M.S. degree in Electrical Engineering & Computer Science (Biomedical Engineering Focus) and a Ph.D. in Neurobiology, from the University of California, Berkeley. He also received an M.D. from Harvard Medical School and the Harvard-MIT Division of Health Sciences and Technology at M.I.T.
DANKE
And I meant, "split," not "slit." Good grief...
Interesting point. I would have thought that, too, but I just looked at the 6 month chart for each and Apple looks like a flight with turbulence, but SPY looks like a one way up escalator with a pretty steep upwards slope.
AAPL’s PE doesn’t look too frothy, but I don’t really know its historical PE either, but I’m guessing the current 35 is on the high end.
I know I'm being lazy, but did they announce a forward slit?
Always great info. Thanks again.
I'm trying to figure if this will finish off Uber and Lyft. Thoughts?
MongoDB Inc - Class A (NASDAQ: MDB), a New York, New York, company, gained to close at $375.76 Monday after gaining $8.1 (2.20%) on volume of 375,375 shares. The stock ranged from a high of $379.61 to a low of $369.83 while MongoDB’s market cap now stands at $23,349,760,218.
Institutions loading up at 365 in the secondary...
Since July 2020, Mark Porter has been CTO at next-generation independent database vendor MongoDB. It's a role he relishes as looks to help grow the company.
MongoDB is a popular open source document database that has made increasing inroads into the database as a service (DBaaS) market with its MongoDB Atlas cloud service. On July 13, Porter helped launch the MongoDB 5.0 platform, which introduced enhanced time series data support as well as live re-sharding.
Porter has had a long and varied career in the data and database market, during which he worked for Oracle for 11 years and was general manager of Amazon's RDS database service for five years.
I don't know how this Company is still under the radar...
Another incredible CEO - LONGGGGG...